SURAKSHA
Start SIP
Invest Now
Start SIP in SURAKSHA
Performance
- Low
- ₹280
- High
- ₹288
- 52 Week Low
- ₹231
- 52 Week High
- ₹353
- Open Price₹282
- Previous Close₹285
- Volume31,024
- 50 DMA₹278.92
- 100 DMA₹286.65
- 200 DMA₹298.02
Investment Returns
- Over 1 Month + 7.24%
- Over 3 Month -8.05%
- Over 6 Month -5.67%
- Over 1 Year -5.09%
Smart Investing Starts Here Start SIP with Suraksha Diagnostic for Steady Growth!
Suraksha Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.6
- PEG Ratio
- 6.4
- Market Cap Cr
- 1,485
- P/B Ratio
- 6.4
- Average True Range
- 8.29
- EPS
- 6.39
- Dividend Yield
- 0
- MACD Signal
- 2.15
- RSI
- 60.68
- MFI
- 67.52
Suraksha Diagnostic Financials
Suraksha Diagnostic Technicals
EMA & SMA
Current Price
₹285.15
+
0.1
(0.04%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹278.31
- 50 Day
- ₹278.92
- 100 Day
- ₹286.65
- 200 Day
- ₹298.02
Resistance and Support
284.27
- R3 296.18
- R2 291.92
- R1 288.53
- S1 280.88
- S2 276.62
- S3 273.23
Suraksha Diagnostic Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-05 | Quarterly Results | |
| 2025-11-10 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-28 | Audited Results & Final Dividend | |
| 2025-02-08 | Quarterly Results |
Suraksha Diagnostic F&O
About Suraksha Diagnostic
- NSE Symbol
- SURAKSHA
- BSE Symbol
- 544293
- Joint Managing Director & CEO
- Ms. Ritu Mittal
- ISIN
- INE877V01027
Similar Stocks to Suraksha Diagnostic
Suraksha Diagnostic FAQs
Suraksha Diagnostic share price is ₹285 As on 15 February, 2026 | 15:41
The Market Cap of Suraksha Diagnostic is ₹1485.1 Cr As on 15 February, 2026 | 15:41
The P/E ratio of Suraksha Diagnostic is 44.6 As on 15 February, 2026 | 15:41
The PB ratio of Suraksha Diagnostic is 6.4 As on 15 February, 2026 | 15:41
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.